Netherlands· NL-2f1ddd3a20f3

Diacomit 500 mg, poeder voor orale suspensie

A stiripentol product containing stiripentol, registered in Netherlands by Biocodex. The same ATC class is registered in 17 of our 19 countries.

ATC N03AX17

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about stiripentolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Stiripentol is registered in 17 of 19 countries.

Countries holding a registration under ATC N03AX17 (stiripentol), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search stiripentol products by name

Stiripentol · ATC N03AX17

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of stiripentol costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Stiripentol · price per daily dose (1 g)

USD · FX 28 Sept 2026

CH Switzerland$16.74

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: STIRIPENTOL
Manufacturer: Biocodex
Country: Netherlands (NL)
ATC code: N03AX17
ATC class: Stiripentol
Defined daily dose: 1 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/06/367

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

307 interactions on record for stiripentol.

Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check stiripentol against other medicines How interaction checks work

Stiripentol · interactions on record

307 records

40 severe
260 moderate
7 minor

Most severe, free to view

CisaprideA03FA02severe
NaloxegolA06AH03severe
EliglustatA16AX10severe
CilostazolB01AC23severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Stiripentol in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All stiripentol products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

United Kingdom (Northern Ireland) · Stiripentol, Stiripentol Kinedexe Uk
Iceland · Diacomit
Liechtenstein · Diacomit
Norway · Diacomit

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f17c1d45-ea7f-4902-ab27-892bd68b9954
GET /v1/drugs/f17c1d45-ea7f-4902-ab27-892bd68b9954?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor orale suspensie",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/diacomit-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Stiripentol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp72949",
  "excipients": [
    "ARABISCHE GOM (E 414)",
    "ASPARTAAM (E 951)",
    "CARMELLOSE NATRIUM (E 466)",
    "ERYTHROSINE (E 127)",
    "GLUCOSESTROOP, GEDEHYDRATEERD",
    "HYDROXYETHYLCELLULOSE",
    "MALTODEXTRINE",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON (E 1201)",
    "SORBITOL (E 420)",
    "TITAANDIOXIDE (E 171)",
    "TUTTI-FRUTTI SMAAKSTOF"
  ],
  "substances": [
    "STIRIPENTOL"
  ],
  "leaflet_url": null,
  "authorised_at": "2007/01/04",
  "procedure_number": "EMEA/H/C/000664",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/06/367",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about stiripentol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console